FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

30006611000001103: Cabergoline 2mg tablets (Mawdsley-Brooks & Company Ltd) 20 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 19-Aug 2015. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
93779901000001116 Cabergoline 2mg tablets (Mawdsley-Brooks & Company Ltd) 20 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
93780001000001115 Cabergoline 2mg tablets (Mawdsley-Brooks & Company Ltd) 20 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Cabergoline 2mg tablets (Mawdsley-Brooks & Company Ltd) 20 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Cabergoline 2mg tablets (Mawdsley-Brooks & Company Ltd) 20 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Cabergoline 2mg tablets (Mawdsley-Brooks & Company Ltd) 20 tablet Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Cabergoline 2mg tablets (Mawdsley-Brooks & Company Ltd) 20 tablet Is a Cabergoline 2mg tablets 20 tablet true Inferred relationship Existential restriction modifier
Cabergoline 2mg tablets (Mawdsley-Brooks & Company Ltd) 20 tablet Has AMP Cabergoline 2mg tablets (Mawdsley-Brooks & Company Ltd) true Inferred relationship Existential restriction modifier
Cabergoline 2mg tablets (Mawdsley-Brooks & Company Ltd) 20 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Cabergoline 2mg tablets (Mawdsley-Brooks & Company Ltd) 20 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Cabergoline 2mg tablets (Mawdsley-Brooks & Company Ltd) 20 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Cabergoline 2mg tablets (Mawdsley-Brooks & Company Ltd) 20 tablet Has specific active ingredient Cabergoline true Inferred relationship Existential restriction modifier
Cabergoline 2mg tablets (Mawdsley-Brooks & Company Ltd) 20 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Cabergoline 2mg tablets (Mawdsley-Brooks & Company Ltd) 20 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Cabergoline 2mg tablets (Mawdsley-Brooks & Company Ltd) 20 tablet Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Cabergoline 2mg tablets (Mawdsley-Brooks & Company Ltd) 20 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start